| Symbol | CMPS |
|---|---|
| Name | COMPASS PATHWAYS PLC |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 33 BROADWICK STREET,3RD FLOOR, LONDON, W1F 0DQ, United Kingdom |
| Telephone | 1-716-676-6461 |
| Fax | — |
| — | |
| Website | https://compasspathways.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001816590 |
| Description | Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. Additional info from NASDAQ: |
Compass Pathways - Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreCompass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreCompass Pathways - Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
Read moreCompass Pathways - Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
Read moreCompass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
Read more📋 Jenkins Annalisa (Ex-Director) plans to sell 26K shares of COMPASS Pathways plc (at $13.30 each, total $346K) Filed: Aug 10, 2026 | ID: 005811
Read more📋 Jenkins Annalisa (Ex-Director) plans to sell 84K shares of COMPASS Pathways plc (at $13.72 each, total $1.1M) Filed: Aug 07, 2026 | ID: 005736
Read moreCompass Pathways - Compass Pathways to Participate in Canaccord Genuitys 46th Annual Growth Conference on August 12, 2026
Read moreCompass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
Read more